Variant report

Variant	esv1829788
Chromosome Location	chr3:84926769-85086403
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr3:85055673-85057144	HepG2	liver:	n/a	chr3:85056293-85056309 chr3:85056322-85056338 chr3:85056292-85056308
2	ATF3	chr3:85014321-85014662	H1-hESC	embryonic stem cell:	n/a	n/a
3	ATF3	chr3:85014281-85014577	H1-hESC	embryonic stem cell:	n/a	n/a
4	ATF3	chr3:85056278-85056714	A549	lung:	n/a	n/a
5	BACH1	chr3:85053329-85053616	H1-hESC	embryonic stem cell:	n/a	n/a
6	BACH1	chr3:85011727-85011885	H1-hESC	embryonic stem cell:	n/a	n/a
7	BACH1	chr3:85008844-85009156	H1-hESC	embryonic stem cell:	n/a	n/a
8	BACH1	chr3:85007700-85007990	H1-hESC	embryonic stem cell:	n/a	n/a
9	BCL3	chr3:85056259-85056743	A549	lung:	n/a	n/a
10	BCL3	chr3:85056181-85056857	A549	lung:	n/a	n/a
11	BHLHE40	chr3:84954233-84954576	HepG2	liver:	n/a	n/a
12	BHLHE40	chr3:85056422-85056714	HepG2	liver:	n/a	n/a
13	BRCA1	chr3:85007545-85007619	H1-hESC	embryonic stem cell:	n/a	n/a
14	CEBPB	chr3:85056334-85056700	IMR90	lung:	n/a	chr3:85056514-85056525 chr3:85056478-85056489
15	CEBPB	chr3:85056318-85057078	A549	lung:	n/a	chr3:85056514-85056525 chr3:85056945-85056956 chr3:85056478-85056489
16	CEBPB	chr3:85056359-85056634	K562	blood:	n/a	chr3:85056514-85056525 chr3:85056478-85056489
17	CEBPB	chr3:85056201-85057105	A549	lung:	n/a	chr3:85056514-85056525 chr3:85056945-85056956 chr3:85056478-85056489
18	CEBPB	chr3:85040390-85040687	HepG2	liver:	n/a	chr3:85040521-85040532 chr3:85040472-85040483 chr3:85040470-85040483 chr3:85040470-85040481 chr3:85040470-85040483
19	CEBPB	chr3:84992560-84992803	H1-hESC	embryonic stem cell:	n/a	n/a
20	CEBPB	chr3:85036362-85036987	A549	lung:	n/a	chr3:85036822-85036833 chr3:85036502-85036513 chr3:85036822-85036835 chr3:85036503-85036512 chr3:85036501-85036512
21	CEBPB	chr3:85052661-85052992	H1-hESC	embryonic stem cell:	n/a	chr3:85052821-85052834 chr3:85052823-85052832 chr3:85052823-85052832 chr3:85052822-85052833 chr3:85052823-85052832 chr3:85052821-85052834 chr3:85052823-85052832 chr3:85052821-85052834 chr3:85052821-85052832
22	CEBPB	chr3:85056316-85056704	Hela-S3	cervix:	n/a	chr3:85056514-85056525 chr3:85056478-85056489
23	CEBPB	chr3:85066421-85066723	A549	lung:	n/a	n/a
24	CEBPB	chr3:85052603-85053081	A549	lung:	n/a	chr3:85052821-85052834 chr3:85052823-85052832 chr3:85052823-85052832 chr3:85052822-85052833 chr3:85052823-85052832 chr3:85052821-85052834 chr3:85052823-85052832 chr3:85052821-85052834 chr3:85052821-85052832
25	CEBPB	chr3:85055972-85056094	A549	lung:	n/a	n/a
26	CEBPB	chr3:85010675-85010724	H1-hESC	embryonic stem cell:	n/a	n/a
27	CEBPB	chr3:85056413-85056685	ECC-1	luminal epithelium:	n/a	chr3:85056514-85056525 chr3:85056478-85056489
28	CEBPB	chr3:85014267-85014637	H1-hESC	embryonic stem cell:	n/a	n/a
29	CEBPB	chr3:85052663-85053003	K562	blood:	n/a	chr3:85052821-85052834 chr3:85052823-85052832 chr3:85052823-85052832 chr3:85052822-85052833 chr3:85052823-85052832 chr3:85052821-85052834 chr3:85052823-85052832 chr3:85052821-85052834 chr3:85052821-85052832
30	CEBPB	chr3:85042549-85042764	H1-hESC	embryonic stem cell:	n/a	n/a
31	CEBPB	chr3:85056360-85056728	HepG2	liver:	n/a	chr3:85056514-85056525 chr3:85056478-85056489
32	CEBPB	chr3:85014296-85014633	Hela-S3	cervix:	n/a	n/a
33	CEBPB	chr3:85052663-85053009	A549	lung:	n/a	chr3:85052821-85052834 chr3:85052823-85052832 chr3:85052823-85052832 chr3:85052822-85052833 chr3:85052823-85052832 chr3:85052821-85052834 chr3:85052823-85052832 chr3:85052821-85052834 chr3:85052821-85052832
34	CEBPB	chr3:84958813-84959139	HepG2	liver:	n/a	chr3:84958954-84958965
35	CEBPB	chr3:85036414-85036614	IMR90	lung:	n/a	chr3:85036502-85036513 chr3:85036503-85036512 chr3:85036501-85036512
36	CEBPB	chr3:85086170-85086355	HepG2	liver:	n/a	chr3:85086271-85086282
37	CEBPB	chr3:85044482-85044772	A549	lung:	n/a	chr3:85044516-85044527 chr3:85044606-85044615 chr3:85044594-85044605
38	CEBPB	chr3:85052636-85053009	HepG2	liver:	n/a	chr3:85052821-85052834 chr3:85052823-85052832 chr3:85052823-85052832 chr3:85052822-85052833 chr3:85052823-85052832 chr3:85052821-85052834 chr3:85052823-85052832 chr3:85052821-85052834 chr3:85052821-85052832
39	CEBPB	chr3:85052649-85052988	IMR90	lung:	n/a	chr3:85052821-85052834 chr3:85052823-85052832 chr3:85052823-85052832 chr3:85052822-85052833 chr3:85052823-85052832 chr3:85052821-85052834 chr3:85052823-85052832 chr3:85052821-85052834 chr3:85052821-85052832
40	CEBPB	chr3:85086253-85086378	H1-hESC	embryonic stem cell:	n/a	chr3:85086271-85086282
41	CEBPB	chr3:85056339-85056689	H1-hESC	embryonic stem cell:	n/a	chr3:85056514-85056525 chr3:85056478-85056489
42	CEBPB	chr3:84958863-84959065	A549	lung:	n/a	chr3:84958954-84958965
43	CEBPB	chr3:85044531-85044781	H1-hESC	embryonic stem cell:	n/a	chr3:85044606-85044615 chr3:85044594-85044605
44	CEBPB	chr3:85056381-85056697	HepG2	liver:	n/a	chr3:85056514-85056525 chr3:85056478-85056489
45	CEBPB	chr3:85056398-85056713	MCF-7	breast:	n/a	chr3:85056514-85056525 chr3:85056478-85056489
46	CEBPB	chr3:85056309-85056780	A549	lung:	n/a	chr3:85056514-85056525 chr3:85056478-85056489
47	CEBPB	chr3:85052648-85052994	Hela-S3	cervix:	n/a	chr3:85052821-85052834 chr3:85052823-85052832 chr3:85052823-85052832 chr3:85052822-85052833 chr3:85052823-85052832 chr3:85052821-85052834 chr3:85052823-85052832 chr3:85052821-85052834 chr3:85052821-85052832
48	CEBPB	chr3:84930983-84931198	A549	lung:	n/a	n/a
49	CEBPB	chr3:85056337-85056780	HepG2	liver:	n/a	chr3:85056514-85056525 chr3:85056478-85056489
50	CEBPB	chr3:85044478-85044775	HepG2	liver:	n/a	chr3:85044516-85044527 chr3:85044606-85044615 chr3:85044594-85044605

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:85007959-85008009	NH-A	brain:	n/a
2	chr3:85007992-85008042	HCM	heart:	n/a
3	chr3:85008156-85008206	AoSMC	blood vessel:	n/a
4	chr3:85006115-85006165	SK-N-MC	brain:	n/a
5	chr3:85008678-85008728	IMR90	lung:	fetal
6	chr3:85008061-85008111	HL-60	blood:	n/a
7	chr3:85079961-85080011	LNCaP	prostate:	n/a
8	chr3:85010606-85010656	GM12892	blood:	n/a
9	chr3:85008156-85008206	HL-60	blood:	n/a
10	chr3:85042454-85042504	GM12878	blood:	n/a
11	chr3:85008061-85008111	NHBE	bronchial:	n/a
12	chr3:85007992-85008042	PrEC	prostate:	n/a
13	chr3:84967895-84967945	NHBE	bronchial:	n/a
14	chr3:85042454-85042504	AG04450	lung:	fetal
15	chr3:85010677-85010727	MCF10A-Er-Src	breast:	n/a
16	chr3:85006115-85006165	A549	lung:	n/a
17	chr3:85054782-85054832	Caco-2	colon:	n/a
18	chr3:85010606-85010656	Hepatocyte	liver:	n/a
19	chr3:85007817-85007867	SK-N-SH_RA	brain:	n/a
20	chr3:85079961-85080011	GM12892	blood:	n/a
21	chr3:84967895-84967945	BJ	skin:	n/a
22	chr3:85007732-85007782	HNPCEpiC	eye:	n/a
23	chr3:85010606-85010656	AG09319	gingival:	n/a
24	chr3:85006115-85006165	ProgFib	skin:	n/a
25	chr3:85042454-85042504	Hela-S3	cervix:	n/a
26	chr3:85005177-85005227	SK-N-MC	brain:	n/a
27	chr3:85079961-85080011	RPTEC	kidney:	n/a
28	chr3:85008828-85008878	HIPEpiC	eye:	n/a
29	chr3:85008587-85008637	Hepatocyte	liver:	n/a
30	chr3:85071786-85071836	Hepatocyte	liver:	n/a
31	chr3:85010606-85010656	U87	brain:	n/a
32	chr3:85008828-85008878	ECC-1	luminal epithelium:	n/a
33	chr3:85007732-85007782	SKMC	muscle:	n/a
34	chr3:85008828-85008878	CMK	blood:	n/a
35	chr3:85007732-85007782	AG04450	lung:	fetal
36	chr3:85005177-85005227	RPTEC	kidney:	n/a
37	chr3:85008991-85009041	SK-N-MC	brain:	n/a
38	chr3:85008828-85008878	BJ	skin:	n/a
39	chr3:85008587-85008637	MCF-7	breast:	n/a
40	chr3:85071786-85071836	GM12891	blood:	n/a
41	chr3:85008061-85008111	GM12892	blood:	n/a
42	chr3:85071786-85071836	MCF-7	breast:	n/a
43	chr3:85079961-85080011	SK-N-SH_RA	brain:	n/a
44	chr3:85071786-85071836	ProgFib	skin:	n/a
45	chr3:85008678-85008728	AG10803	skin:	n/a
46	chr3:85008061-85008111	HCT-116	colon:	n/a
47	chr3:85007732-85007782	AG09319	gingival:	n/a
48	chr3:85007894-85007944	GM12891	blood:	n/a
49	chr3:85008587-85008637	HCM	heart:	n/a
50	chr3:85008678-85008728	GM19239	blood:	n/a

No.	Distal block	Cell Line	Cell type
1	chr3:84992684..84993232-chr3:85391799..85392321,2	MCF-7	breast:
2	chr3:85029590..85031359-chr3:85035312..85037118,2	K562	blood:
3	chr3:85029590..85031359-chr3:85035312..85037118,2	K562	blood:
4	chr3:85038561..85040690-chr3:85042508..85045093,2	MCF-7	breast:
5	chr3:85011548..85014009-chr3:85014905..85018347,3	MCF-7	breast:
6	chr3:84968846..84970373-chr6:74221820..74224403,2	K562	blood:
7	chr3:85079311..85079892-chr9:126116062..126116943,2	MCF-7	breast:
8	chr3:84967378..84970376-chr6:74219853..74222987,3	MCF-7	breast:
9	chr3:85038561..85040690-chr3:85042508..85045093,2	MCF-7	breast:
10	chr3:85011548..85014009-chr3:85014905..85018347,3	MCF-7	breast:
11	chr3:85023240..85023756-chr3:85409642..85410352,2	MCF-7	breast:
12	chr3:84994697..84996927-chr3:85551100..85552839,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-VGLL3-9	chr3:84995057-84995277	ucscGeneNc_uc003dqi_2
2	lnc-VGLL3-9	chr3:84995547-84995846	ucscGeneNc_uc003dqi_2
3	lnc-VGLL3-9	chr3:85001119-85001416	ucscGeneNc_uc003dqi_2
4	lnc-CADM2-1	chr3:84934086-84934274	NONHSAT090654
5	lnc-CADM2-1	chr3:84934087-84934274	XLOC_002723
6	lnc-VGLL3-9	chr3:84991656-84991764	ucscGeneNc_uc003dqi_2
7	lnc-VGLL3-9	chr3:84994564-84994662	ucscGeneNc_uc003dqi_2
8	lnc-CADM2-1	chr3:84942082-84942116	NONHSAT090654
9	lnc-CADM2-1	chr3:84942392-84942530	NONHSAT090654
10	lnc-CHMP2B-6	chr3:85009248-85009589	NONHSAT090658
11	lnc-CHMP2B-6	chr3:85008741-85008787	NONHSAT090657
12	lnc-VGLL3-9	chr3:85000744-85000865	ucscGeneNc_uc003dqi_2
13	lnc-VGLL3-9	chr3:85000439-85000509	ucscGeneNc_uc003dqi_2
14	lnc-CHMP2B-6	chr3:85008156-85008819	NONHSAT090658
15	lnc-CADM2-1	chr3:84942393-84942530	XLOC_002723
16	lnc-VGLL3-6	chr3:84930640-84930830	ENSG00000242641.1
17	lnc-VGLL3-9	chr3:84985783-84985856	ucscGeneNc_uc003dqi_2
18	lnc-CHMP2B-6	chr3:85008140-85008643	NONHSAT090657
19	lnc-CADM2-1	chr3:84942083-84942116	XLOC_002723

Variant related genes	Relation type
ENSG00000266025	TF binding region
CADM2	TF binding region
ENSG00000242339	TF binding region
LINC00971	TF binding region
ENSG00000266025	CpG island
CADM2	CpG island
ENSG00000242339	CpG island
LINC00971	CpG island
TCEAL1	miRNA target sites
YES1	miRNA target sites
THAP6	miRNA target sites

Extended variants
information (count: 3437 )
Associated
traits (count: 81 )

Variant overlapped rSNPs/rCNVs (count:3437 , 50 per page) page: 1 2 3 4 5 6 7 ... 69

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs13083529	chr3:84926769-84926770	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs112766048	chr3:84926793-84926794	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs553393991	chr3:84928212-84928213	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs383685	chr3:84928214-84928215	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs538873722	chr3:84928216-84928217	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs150256908	chr3:84928226-84928227	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs191769379	chr3:84928235-84928236	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs543436830	chr3:84928253-84928254	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs555440982	chr3:84928300-84928301	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs201214448	chr3:84928307-84928308	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs111465434	chr3:84928308-84928309	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs541282342	chr3:84928331-84928332	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs559413005	chr3:84928339-84928340	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs76245946	chr3:84928351-84928352	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs544909495	chr3:84928394-84928395	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs563783473	chr3:84928396-84928397	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs375642091	chr3:84928404-84928405	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs549074871	chr3:84928444-84928445	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs368325534	chr3:84928466-84928467	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs183573972	chr3:84928476-84928477	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs12494212	chr3:84928479-84928480	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs372881510	chr3:84928496-84928497	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs76782294	chr3:84928611-84928612	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs571878967	chr3:84928636-84928637	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs571971253	chr3:84928639-84928640	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs149259543	chr3:84928691-84928692	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs371689371	chr3:84928782-84928783	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs80315797	chr3:84928786-84928787	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs1146740	chr3:84928792-84928793	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs142389765	chr3:84929647-84929648	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs182373840	chr3:84929665-84929666	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs78071490	chr3:84930292-84930293	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs557518466	chr3:84930299-84930300	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs142162156	chr3:84930385-84930386	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs546685925	chr3:84930654-84930655	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
36	rs533234696	chr3:84930674-84930675	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
37	rs560298593	chr3:84930679-84930680	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
38	rs571128082	chr3:84930712-84930713	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
39	rs538643321	chr3:84930727-84930728	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
40	rs1248821	chr3:84930747-84930748	Inactive region	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs545636150	chr3:84930778-84930779	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
42	rs147907360	chr3:84931041-84931042	Inactive region	TF binding region	2 gene(s)	Overlapped CNVs	n/a
43	rs559033592	chr3:84931042-84931043	Inactive region	TF binding region	2 gene(s)	Overlapped CNVs	n/a
44	rs182824634	chr3:84931051-84931052	Inactive region	TF binding region	2 gene(s)	Overlapped CNVs	n/a
45	rs544654887	chr3:84931061-84931062	Inactive region	TF binding region	2 gene(s)	Overlapped CNVs	n/a
46	rs563156635	chr3:84931066-84931067	Inactive region	TF binding region	2 gene(s)	Overlapped CNVs	n/a
47	rs62251965	chr3:84931083-84931084	Inactive region	TF binding region	2 gene(s)	Overlapped CNVs	n/a
48	rs188259977	chr3:84931117-84931118	Inactive region	TF binding region	2 gene(s)	Overlapped CNVs	n/a
49	rs542434109	chr3:84931144-84931145	Inactive region	TF binding region	2 gene(s)	Overlapped CNVs	n/a
50	rs531268580	chr3:84931189-84931190	Inactive region	TF binding region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:81)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Melanoma	18172304	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Insulin resistance	16721378	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Oral cancer	19627613	CNVD
Renal cell carcinoma	19461508	CNVD
Epithelial cancer	22065749	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Acute myeloid leukemia	16864856	CNVD
Liposarcoma	21253554	CNVD
Basal cell lymphoma	21115979	CNVD
Endometrial cancer	22040021	CNVD
Pancreatic endocrine tumor	20981439	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Oral cancer	21386901	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Acute myeloid leukemia	20729466	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Retinoblastoma	21504564	CNVD
Renal cell carcinoma	21668985	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17603634	CNVD
Esophageal cancer	20955586	CNVD
Uveal melanoma	20484589	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Hirschsprung''s Disease	21712996	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21183584	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Bipolar disorder	20877625	CNVD
Bipolar disorder	21956041	CNVD
Bipolar disorder	22241247	CNVD
Biliary cancer	18923514	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Prostate cancer	21965145	CNVD
Cancer	21129771	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Cervical cancer	21062161	CNVD
Squamous cell cancer	20885788	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20164919	CNVD
Metanephric adenoma	20802469	CNVD
Bipolar disorder	18458673	CNVD
Breast cancer	22032731	CNVD
Wilms tumour	21544195	CNVD
Colorectal cancer	16272173	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Soft tissue tumor	16732325	CNVD
Breast cancer	21858162	CNVD
small cell lung cancer	20016488	CNVD
Neurodevelopmental disorder	22521361	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Mental retardation	17124404	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Myelofibrosis	22110671	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
craniofacial dysmorphism	21918468	CNVD
Schizophrenia	23813976	CNVD
Lung squamous cell carcinoma	22363434	CNVD
Autism	22102821	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
early-passage human iPS cells	21368824	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:1157 , 50 per page) page: 1 2 3 4 5 6 7 ... 24

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:84926200-84926800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
2	chr3:84926400-84926800	Enhancers	Placenta Amnion	Placenta Amnion
3	chr3:84928200-84928800	Enhancers	Brain Hippocampus Middle	brain
4	chr3:84934200-84934600	ZNF genes & repeats	Pancreas	Pancrea
5	chr3:84953800-84955600	Enhancers	Fetal Muscle Leg	muscle
6	chr3:84954000-84954200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
7	chr3:84954000-84954200	Enhancers	Psoas Muscle	Psoas
8	chr3:84954000-84954200	Active TSS	Skeletal Muscle Male	skeletal muscle
9	chr3:84954000-84954200	Enhancers	Skeletal Muscle Female	skeletal muscle
10	chr3:84954000-84955600	Enhancers	Fetal Muscle Trunk	muscle
11	chr3:84954200-84954600	Enhancers	H1 Cell Line	embryonic stem cell
12	chr3:84954200-84954600	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
13	chr3:84954200-84954600	Enhancers	Muscle Satellite Cultured Cells	--
14	chr3:84954200-84954600	Flanking Active TSS	Psoas Muscle	Psoas
15	chr3:84954200-84954600	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
16	chr3:84954200-84955400	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
17	chr3:84954600-84954800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
18	chr3:84954600-84955000	Enhancers	Skeletal Muscle Male	skeletal muscle
19	chr3:84954600-84955400	Enhancers	Psoas Muscle	Psoas
20	chr3:84955000-84955400	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
21	chr3:84955400-84955600	Enhancers	Skeletal Muscle Male	skeletal muscle
22	chr3:84955400-84955600	Enhancers	Skeletal Muscle Female	skeletal muscle
23	chr3:84964400-84964600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
24	chr3:84968400-84968600	ZNF genes & repeats	Duodenum Smooth Muscle	Duodenum
25	chr3:84974400-84975200	Enhancers	Brain Cingulate Gyrus	brain
26	chr3:84974600-84975400	Active TSS	Brain Angular Gyrus	brain
27	chr3:84974800-84975200	Active TSS	Brain Inferior Temporal Lobe	brain
28	chr3:84974800-84975400	Active TSS	Brain Hippocampus Middle	brain
29	chr3:84975200-84975400	Enhancers	Brain Inferior Temporal Lobe	brain
30	chr3:84975400-84976200	Weak transcription	Brain Inferior Temporal Lobe	brain
31	chr3:84975400-84976400	Enhancers	Brain Hippocampus Middle	brain
32	chr3:84975600-84976000	Enhancers	Brain Angular Gyrus	brain
33	chr3:84976200-84976400	Enhancers	Brain Inferior Temporal Lobe	brain
34	chr3:84976200-84976600	Enhancers	Brain Substantia Nigra	brain
35	chr3:84985200-84985400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
36	chr3:84985400-84985800	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
37	chr3:84985800-84986000	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
38	chr3:84992000-84992800	Enhancers	Psoas Muscle	Psoas
39	chr3:84992200-84992800	Enhancers	Brain Hippocampus Middle	brain
40	chr3:85003600-85007600	Weak transcription	Fetal Brain Male	brain
41	chr3:85004800-85005000	Active TSS	Primary T helper naive cells from peripheral blood	blood
42	chr3:85005000-85007600	Weak transcription	Primary T helper naive cells from peripheral blood	blood
43	chr3:85005200-85005800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
44	chr3:85005800-85006200	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
45	chr3:85006200-85006600	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
46	chr3:85006400-85006600	Enhancers	HUES6 Cell Line	embryonic stem cell
47	chr3:85006400-85007000	Enhancers	iPS-20b Cell Line	embryonic stem cell
48	chr3:85006400-85007200	Enhancers	ES-I3 Cell Line	embryonic stem cell
49	chr3:85006400-85007200	Enhancers	HUES64 Cell Line	embryonic stem cell
50	chr3:85006600-85007200	Enhancers	HUES48 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links